Back to Search Start Over

Allylphenols as a new class of human 15‐lipoxygenase‐1 inhibitors

Authors :
Seyed Mohammad Seyedi
Satar Saberi
Seyed Jamal Alavi
Hamid Sadeghian
Hossein Eshghi
Hadi Safdari
Source :
Drug Development Research. 82:259-266
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

In this study, a series of mono- and diallylphenol derivative were designed, synthesized, and evaluated as potential human 15-lipoxygenase-1 (15-hLOX-1) inhibitors. Radical scavenging potency of the synthetic allylphenol derivatives was assessed and the results were in accordance with lipoxygenase (LOX) inhibition potency. It was found that the electronic natures of allyl moiety and para substituents play the main role in radical scavenging activity and subsequently LOX inhibition potency of the synthetic inhibitors. Among the synthetic compounds, 2,6-diallyl-4-(hexyloxy)phenol (42) and 2,6-diallyl-4-aminophenol (47) showed the best results for LOX inhibition (IC50 = 0.88 and 0.80 μM, respectively).

Details

ISSN :
10982299 and 02724391
Volume :
82
Database :
OpenAIRE
Journal :
Drug Development Research
Accession number :
edsair.doi.dedup.....90ee400f01d09e16b36af10cc50acd03
Full Text :
https://doi.org/10.1002/ddr.21749